Alternative To Castration for Early Prostate Cancers
Prostate Cancer Study
For those unwilling to undergo chemical castration however, results of an international study led by a Medical College of Wisconsin researcher show promise for an oral drug as an alternative to castration for early prostate cancers. The study appears in the August issue of the Journal of Cancer Research and Clinical Oncology.
"In patients with locally-advanced disease, a daily 150 mg dose of bicalutamide, (Casodex
The double-blind, randomized study followed 1,370 early prostate cancer patients in the U.S., Sweden and Europe who received radiotherapy with curative intent. After a median follow-up of 7.2 years, the researchers found that those receiving a daily, 150 mg oral dose of Casodex